Clinical Report: A Nomogram Utilizing Standard Blood Parameters to Assess the Risk of Extended Fever in Pediatric Patients with Primary Epstein-Barr Virus Infection
Overview
This study developed a nomogram using routine blood parameters to predict prolonged fever in children with acute primary Epstein-Barr virus (EBV) infection. The nomogram demonstrated an area under the curve (AUC) of 0.728.
Background
Epstein-Barr virus (EBV) infection is common in children and can lead to prolonged fever, which increases distress for patients and families. Identifying children at risk for extended fever is crucial for managing expectations and guiding clinical observation. Current predictive tools are limited.
Data Highlights
Parameter
Group with Prolonged Fever
Group with Short Fever
Antiviral Therapy
100%
56.1%
Key Findings
Prolonged fever occurred in 27.4% of the cohort.
Antiviral therapy was administered to all patients with prolonged fever (100%).
White blood cell count (WBC), neutrophil count (NEU), platelet count (PLT), and atypical lymphocyte proportion (AL) were identified as optimal predictors.
The nomogram achieved an AUC of 0.728 (95% CI: 0.689–0.768).
Calibration and decision curve analysis confirmed the nomogram's clinical utility.
Clinical Implications
The developed nomogram provides a tool for risk stratification of children with primary EBV infection.
Conclusion
The nomogram based on routine blood parameters offers a method for predicting prolonged fever in pediatric EBV infections.